Objectives. To evaluate the relation between lower urinary tract symptoms (LUTS) as measured by the International Prostate Symptom Score (IPSS) and noninvasive objective parameters of lower urinary tract dysfunction. Methods. Eight hundred three consecutive patients with LUTS and/or benign prostatic hyperplasia were evaluated with IPSS, uroflowmetry, prostate volume estimation, and postvoiding residue measurement. The relations between these parameters were quantified by means of Spearman correlation coefficients. Results. Statistically significant but weak correlations were found between the IPSS and results of uroflowmetry and postvoiding residual urine. There was no correlation between the IPSS and results of prostate volume measurements. Conclusions. The correlation between objective noninvasive parameters of lower urinary tract dysfunction and LUTS is weak.
T he development of prostatic enlargement sec ondary to benign prostatic hyperplasia (BPH) and the development of lower urinary tract symp toms (LUTS) are frequent events in aging males.1 Most patients who seek medical advice do so be cause of bothersome symptoms,2 Consequently, symptoms have become the major focus in the management of bladder outlet obstruction due to BPH.3 Many urologists use the symptoms as the basis for diagnosis of outlet obstruction and for assessment of treatment efficacy. A number of symptom scores have been designed in search of an objective and structured history of symptoms. Nowadays, the most widely used symptom score is the international Prostate Symptom Score (IPSS). It is generally assumed that the IPSS is a reliable and valid instrument to measure subjec tive severity of symptoms and symptom progrès- C o p y r i g h t 1996 b y E l s e v ie r Sc i e n c e I n c . ALL RIGHTS RESERVED sion over time. 4 Besides subjective parameters, changes in objective parameters are used to eval uate treatment success. Because treatment of BPH usually focuses on bladder outlet obstruction, the objective parameters ideally quantify the improve ment in grade of obstruction. Urodynamic inves tigation with pressure-flow analysis is the refer ence standard to measure grade of obstruction. Its role in the diagnostic armamentarium of BPH, however, is controversial. Urodynamic investiga tions are invasive and time consuming.5 Moreover, there is a large equivocal area in the pressure-flow relationship in which "ruling-out" obstruction is difficult.
From
To document obstruction, most urologists still use noninvasive objective parameters such as uri nary flow rate, residual urine, and prostate vol ume. Uroflowmetry is almost universally available and easy to perform, and it is probably the most frequently used test in urology today.0,7 Uroflow and, especially, maximum flow rate (Qmax) are used equivalently with pressure-flow studies to de fine bladder outlet obstruction. Although uroflow describes the relation between detrusor activity and outflow, current opinion holds that if Qmax is lower than 10 mL/s, the patient is most likely Currently, no agreement exists among urologists concerning the minimal requirements for diagno sis and follow-up of patients with LUTS or BPH* Moreover, the correlation between several of these parameters has been questioned. The present study was conducted on a large series of patients to evaluate the relation between LUTS, as mea sured by IPSS, and objective noninvasive param eters of lower urinary tract function.
MATERIAL AND METHODS
We studied 803 consecutive patients with LUTS and/or BPH. All patients included in the present study were subjected to a standardized diagnostic program including history (in cluding IPSS), physical examination (including digital rectal examination), biochemistry (including prostate-specific an tigen), urinalysis and culture, urine cytology, and urodynamic investigations that included pressure-flow studies. Pa tients with a total IPSS of less than 8, 8 to .19, or greater than 19 were considered to have mild, moderate, or severe symp toms, respectively.10 The total score of questions 2, 4, and 7 represents the filling component of the IPSS, whereas the total score of questions 1, 3, 5, and 6 represents the voiding com ponent. Free uroflowmetry was performed in private when the patient presented with normal to severe urge to void. Flow was measured using a Dantec Urodyn 1000 flowmeter. Ac cording to Abrams and Griffiths,8 a maximum flow rate ex ceeding 15 mL/s generally indicates unobstructed micturi tion, whereas values below 10 mL/s indicate infravesical obstruction, provided detrusor insufficiency is absent. Pa tients involved in uroflowmetry studies were considered for the study if the voided volume was 150 mL or greater. Sev enty-four patients did not fulfill this requirement. The data from the remaining 729 patients were used for analysis.
The prostate size was determined using the Kretz Combison 330 ultrasound scanner with a 7,5-MHz transrectal probe ( Multi 3-D VRW 77 AK), The prostate was imaged from base to apex; the presence of prostate abnormalities was docu mented, Prostate volume was measured by the planimetrie method.11 The same ultrasound scanner was used in combi nation with a transabdominal probe (Kretz AWP 3.5) for the estimation of urine residue directly after performing uroflowme try.
For statistical analysis, we used descriptive statistics and the Spearman correlation coefficient (r) to describe the as sociation between IPSS questions and the various tested pa rameters. Comparisons among groups of symptom score were made using the Kruskal-Wallis test.
RESULTS
Descriptive statistics with respect to the patients5 ages, flow results, prostate volumes, and postvoid ing residual urine measurements are summarized in Table I . The mean (± SD ) age of the patients was 63.5 ± 8.4 years, and the mean total IPSS, the voiding subscore, and the filling subscore were 17 ± 7, 9.7 ± 4.8, and 7.3 ± 3.4, respectively. W hen the patients were classified according to the IPSS, the mild-symptom group included 71 patients, the moderate-symptom group included 392 patients, and the severe-symptom group included 266 pa tients. There were small but statistically significant differences between IPSS classes and Qmax and residual urine measurement. In Table II , we cor related the individual IPSS questions with each of the four parameters mentioned above. Interest ingly, we found only a small correlation between the Qmax and weak stream (question 5 ). The same holds for incomplete emptying of the bladder (question 1) and residual urine (r = 0.17). Sta tistically significant but weak correlations were also found between all questions of IPSS and Qmax and residual urine, and for prostate volume with questions 4 (urgency) and 5 (weak stream). All the tested parameters have a correlation with the total IPSS except prostate volume. In addition, the ages of the patients correlated significantly with Qmax, prostate volume, and residual urine but not with the total IPSS. However, all correla tions are small (Table III) .
The relationship between the grade of total IPSS and the results of the Qmax is shown in Figure  1A . An increase in the severity of symptoms sig nificantly correlates with a decrease in flow rate, but the overlap in flow rate between patients with different scores is considerable. Figures IB and 1C represent the relationships between postvoid re sidual urine measurements and prostate volumes and the different grade of the IPSS. A weak asso ciation exists between the residual urine and dif ferent grades of symptoms, but no correlation was found between prostate volume and severity of symptoms.
COMMENT t
In the present study, we evaluated the relation ship between LUTS due to BPH as measured by IPSS and objective noninvasive parameters of lower urinary tract dysfunction. Our study shows that the overall symptom severity correlates only weakly with the results of uroflowmetry and postvoiding residual urine measurements. Symptom severity does not correlate at all with the prostate volume and ages of the patients. The weak corre lation between symptoms and urinary flow rate was shown before by Barry et al.10 However, prob lems with the urinary flow rate in regard to mea surement errors, systematic learning effect, and the main difference between physiologic outlet ob struction and the symptoms associated with BPH are known.6,7 As illustrated by Figure 1A , there is a weak association between severity of symptoms and urinary flow rate. This supports the hypo thesis that the symptoms may originate from neurophysiologic changes that may or may not be as sociated with histologic and anatomic BPH. From this we conclude that, for an individual patient, the lack of correlation between symptoms and flow rate results should not alter the diagnosis of BPH.
The relationship between prostate volume and parameters for bladder outlet obstruction has also been studied by others, in our study, it was shown that no correlation exists between the IPSS and prostate volume. This lack of correlation can occur because hyperplasia may be associated with striking lateral lobe enlargement but symptoms may be negligible if the degree of obstruction is not severe. Conversely, BPH may be associated with a relatively small-sized prostate and marked obstructive symptoms if the obstructing tissue originates exclusively within the central zone of the periurethral gland area. 13 In Figure 1C , we demonstrated the absence of any relationship be tween prostate volume and the severity of symp toms.
Determination of postvoiding residual urine pro vides one of the most effective methods of evaluation of patients during a period of watchful waiting and monitoring response to treatment. Also, large studies on urodynamic results of surgical treatment of BPH have shown that the volume of residual urine sig nificantly decreases after surgery.14 In our study, we evaluated the relation between postvoiding residual urine and Qmax and severity of symptoms. A statis tically significant correlation was found among all IPSS questions and residual urine and Qmax. How- ever, the clinical significance of this finding is minimal, because there exists a great overlap in symp tom score between patients with different grades of obstruction.
From the current study, we conclude that the correlation between the uroflowmetry results, prostate volume, postvoid residual urine, and LUTS as measured by the IPSS is weak. Moreover, the main problem in the documentation of out come of treatment of BPH consists of achieving agreement in the use of the different parameters. Should we aim at improvement of symptoms only, at improvement of the objective voiding parame ters, or even at improvement of both?
